Literature DB >> 17071631

Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity.

D S Kim1, J A Franklyn, V E Smith, A L Stratford, H N Pemberton, A Warfield, J C Watkinson, T Ishmail, M J O Wakelam, C J McCabe.   

Abstract

Genetic instability (GI) is a hallmark feature of tumor development. Securin, also known as pituitary tumor transforming gene (PTTG), is a mitotic checkpoint protein which is highly expressed in numerous cancers, is associated with tumor invasiveness, and induces GI in thyroid cells. We used fluorescence inter-simple sequence repeat PCR to assess GI caused primarily by DNA breakage events in 19 colorectal tumors. GI values ranged significantly, with Dukes' stage C&D colorectal tumors exhibiting greater GI and higher securin expression than Dukes' stage A&B tumors. Consistent with these findings, we observed a dose-dependent increase in GI in HCT116 cells in response to securin overexpression, as well as in non-transformed human fibroblasts. As securin has been implicated in a novel DNA repair pathway in fission yeast, we investigated its potential role in chemotoxic DNA damage response pathways in mammalian cells, using host cell reactivation assays. Securin overexpression in HCT116 cells inhibited etoposide-induced double-stranded DNA damage repair activity, and repressed Ku heterodimer function. Additionally, we observed that securin and Ku70 showed a reciprocal cytosol-nuclear translocation in response to etoposide-induced dsDNA damage. Our data suggest that, by repressing Ku70 activity and inhibiting the non-homologous end-joining dsDNA repair pathway, securin may be a critical gene in the development of GI in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071631     DOI: 10.1093/carcin/bgl202

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

1.  Expression profile of DNA damage signaling genes in 2 Gy proton exposed mouse brain.

Authors:  Sudhakar Baluchamy; Ye Zhang; Prabakaran Ravichandran; Vani Ramesh; Ayodotun Sodipe; Joseph C Hall; Olufisayo Jejelowo; Daila S Gridley; Honglu Wu; Govindarajan T Ramesh
Journal:  Mol Cell Biochem       Date:  2010-04-11       Impact factor: 3.396

2.  MiRNA-494 inhibits metastasis of cervical cancer through Pttg1.

Authors:  Bing Chen; Zhaohui Hou; Chundong Li; Ying Tong
Journal:  Tumour Biol       Date:  2015-04-16

Review 3.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

4.  Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.

Authors:  Mi-die Xu; Lei Dong; Peng Qi; Wei-wei Weng; Xiao-han Shen; Shu-juan Ni; Dan Huang; Cong Tan; Wei-qi Sheng; Xiao-yan Zhou; Xiang Du
Journal:  Gastric Cancer       Date:  2015-01-28       Impact factor: 7.370

5.  Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene.

Authors:  Ursula E Lee; Zahra Ghiassi-Nejad; Andrew J Paris; Steven Yea; Goutham Narla; Martin Walsh; Scott L Friedman
Journal:  FEBS Lett       Date:  2010-01-30       Impact factor: 4.124

6.  p21(Cip1) restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kalman Kovacs; Anat Ben-Shlomo; Kolja Wawrowsky; Serguei Bannykh; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

7.  E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.

Authors:  Cuiqi Zhou; Kolja Wawrowsky; Serguei Bannykh; Shiri Gutman; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-10-16

Review 8.  Acromegaly pathogenesis and treatment.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

9.  Induction of Dlk1 by PTTG1 inhibits adipocyte differentiation and correlates with malignant transformation.

Authors:  Agueda G Espina; Cristina Méndez-Vidal; Miguel A Moreno-Mateos; Carmen Sáez; Ana Romero-Franco; Miguel A Japón; José A Pintor-Toro
Journal:  Mol Biol Cell       Date:  2009-05-28       Impact factor: 4.138

10.  Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Tami Rubinek; Run Yu; Anat Ben-Shlomo; Kalman Kovacs; Kolja Wawrowsky; Shlomo Melmed
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.